To view this email as a web page, click here.
 
Blood pressure drug recall expands
Soon after FDA warned the manufacturer involved in a massive nationwide recall of valsartan- and losartan-containing drugs, the recall is expanding.
Read more
 
Novel pair of therapies offers hope to patients with rare blood disorders
Two new therapies recently approved by FDA signal significant advancement in treating rare blood diseases.
Read more
 
Four ways treatments for autoimmune conditions could change
From our sister brand, Managed Healthcare Executive: Most autoimmune diseases don't have cures. Here are the top ways providers can manage and control them.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.